Heart Failure Study: The Atlanta Cardiomyopathy Consortium

计划入组 335 人 · 首次发布于 2008 年 1 月 23 日

TAKO-TSUBO Cardiomyopathy and Genetic

计划入组 530 人 · 首次发布于 2012 年 1 月 30 日

Genetic Basis of Pacing-induced Cardiomyopathy

计划入组 153 人 · 首次发布于 2017 年 10 月 23 日

cardiomyopathy program

Cardiomyopathy(Kate Therapeutics)

genetic modifier

CENTER FOR VASCULAR AWARENESS

United States

Genetic Immunity

United States

MALARIA CONSORTIUM

United States

Affinia Therapeutics Partners with DCM Foundation to Advance BAG3 Dilated Cardiomyopathy Awareness and Genetic Testing

RP-A501 Gene Therapy Shows Long-Term Promise in Danon Disease

Danicamtiv Shows Promise in Phase 2a Trial for Genetic Dilated Cardiomyopathy